The Board proposes the rule amendment to update the language to include new vaccines and to update the application.

 

DEPARTMENT OF HEALTH
Board of Pharmacy

RULE NO.: RULE TITLE:
64B16-26.1031: Influenza Immunization Certification Program and Application
PURPOSE AND EFFECT: The Board proposes the rule amendment to update the language to include new vaccines and to update the application.
SUMMARY: New vaccines will be included in the rule. The application will be revised.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:
The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the agency.
The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 465.005 FS.
LAW IMPLEMENTED: 465.189 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Mark Whitten, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254

THE FULL TEXT OF THE PROPOSED RULE IS:

64B16-26.1031 Vaccine Influenza Immunization Certification Program.

(1) All applications for vaccine immunization certification programs shall be made on board approved form DH-MQA PH 109, Revised 10/12, Continuing Education Provider Application DH-MQA 1234, “Vaccine Immunization Certification Program Application”, effective 04/10, which is hereby incorporated by reference. To obtain an application, contact the Board of Pharmacy at 4052 Bald Cypress Way, Bin #C04, Tallahassee, FL 32399-3254 or [phone], or download the application from the board’s website at http://www.doh.state.fl.us/mqa/pharmacy.

(2) The Board shall approve for initial certification of pharmacist administration of vaccines influenza immunizations, programs of study not less than 20 hours that include coursework covering all of the following;

(a) through (k) No change.

(l) Administration of epinephrine using an autoinjector delivery system.

(m)(l) The current influenza, pneumococcal and shingles vaccine immunization guidelines and recommendations of the United States Department of Health Centers for Disease Control and Prevention published at www.cdc.gov/vaccines in the Morbidity Weekly Report (MMWR) December 1, 2006, Vol. 55 No. RR-15 and updated MMWR July 13, 2007, Vol. 56, No. RR-6;

(n)(m) No change.

(o)(n) No change.

Successful completion of the certification program must include a successful demonstration of competency in the administration technique and a cognitive examination.

Rulemaking Authority 465.005 FS. Law Implemented 465.189 FS. History–New 3-20-08, Amended 8-30-10,                    .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy
NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: October 9, 2012
DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: October 1, 2012